Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Current and future drugs for treatment of MS-associated bladder dysfunction.
Gap junction pathology in multiple sclerosis lesions and normal-appearing white matter.
Biplanar MRI for the assessment of the spinal cord in multiple sclerosis.
The effect of vitamin a supplementation on disease progression, cytokine levels and gene expression in multiple sclerotic patients: study protocol for a randomized controlled trial.
Absence of mannose-binding lectin in a female with relapsing-remitting multiple sclerosis.
Iron and Non-Iron-Related Characteristics of Multiple Sclerosis and Neuromyelitis Optica Lesions at 7T MRI.
Assessing the potential impact of non-proprietary drug copies on quality of medicine and treatment in patients with relapsing multiple sclerosis: the experience with fingolimod.
No association between chronic cerebrospinal venous insufficiency and pediatric-onset multiple sclerosis.
A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
SMAD family proteins: the current knowledge on their expression and potential role in neoplastic diseases.
The olfactory vector hypothesis of neurodegenerative disease: is it viable?
FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system.
Naltrexone
IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases.
Phase-Sensitive Inversion-Recovery MRI Improves Longitudinal Cortical Lesion Detection in Progressive MS.
Incidence of Mood or Anxiety Disorders in Children of Parents with Multiple Sclerosis.
Ocular Findings in Alemtuzumab (Campath-1H)-induced Thyroid Eye Disease.
Association of NOD1 and NOD2 polymorphisms with Guillain-Barré syndrome in Northern Indian population.
Patients with MS under daclizumab therapy mount normal immune responses to influenza vaccination.
PLEGRIDY™ (peginterferon beta-1a) two-year data confirm maintenance of efficacy and safety in multiple sclerosis patients
Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis.
Association of IL4 and IL4R polymorphisms with multiple sclerosis susceptibility in Caucasian population: A meta-analysis.
Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning.
Proton Density MRI Increases Detection of Cervical Spinal Cord Multiple Sclerosis Lesions Compared with T2-Weighted Fast Spin-Echo.
Massive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMO.

Pages